EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 192 filers reported holding EDITAS MEDICINE INC in Q2 2019. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $320,221 | +16.1% | 41,054 | +22.5% | 0.00% | 0.0% |
Q2 2023 | $275,771 | +14.1% | 33,508 | +0.5% | 0.00% | 0.0% |
Q1 2023 | $241,737 | -16.6% | 33,343 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $289,863 | -27.7% | 32,679 | -0.4% | 0.00% | -33.3% |
Q3 2022 | $401,000 | +4.7% | 32,798 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $383,000 | -40.7% | 32,335 | -4.8% | 0.00% | -25.0% |
Q1 2022 | $646,000 | -33.1% | 33,955 | -6.6% | 0.00% | -20.0% |
Q4 2021 | $965,000 | -37.3% | 36,345 | -2.9% | 0.01% | -37.5% |
Q3 2021 | $1,538,000 | -29.2% | 37,432 | -2.3% | 0.01% | +14.3% |
Q2 2021 | $2,171,000 | +32.9% | 38,321 | -1.5% | 0.01% | +16.7% |
Q1 2021 | $1,634,000 | -36.2% | 38,908 | +6.6% | 0.01% | -33.3% |
Q4 2020 | $2,560,000 | +142.9% | 36,509 | -2.8% | 0.01% | +80.0% |
Q3 2020 | $1,054,000 | +5.1% | 37,556 | +10.7% | 0.01% | 0.0% |
Q2 2020 | $1,003,000 | +65.2% | 33,924 | +10.8% | 0.01% | +66.7% |
Q1 2020 | $607,000 | -36.7% | 30,621 | -5.5% | 0.00% | -25.0% |
Q4 2019 | $959,000 | +34.5% | 32,389 | +3.4% | 0.00% | +33.3% |
Q3 2019 | $713,000 | -8.7% | 31,339 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $781,000 | +8.3% | 31,556 | +7.0% | 0.00% | 0.0% |
Q1 2019 | $721,000 | +4.2% | 29,480 | -3.1% | 0.00% | 0.0% |
Q4 2018 | $692,000 | -28.2% | 30,435 | +0.5% | 0.00% | 0.0% |
Q3 2018 | $964,000 | -9.5% | 30,281 | +1.8% | 0.00% | -25.0% |
Q2 2018 | $1,065,000 | +35.5% | 29,735 | +25.4% | 0.00% | +33.3% |
Q1 2018 | $786,000 | +10.2% | 23,710 | +2.2% | 0.00% | +50.0% |
Q4 2017 | $713,000 | +31.1% | 23,199 | +2.4% | 0.00% | 0.0% |
Q3 2017 | $544,000 | +54.5% | 22,665 | +8.1% | 0.00% | +100.0% |
Q2 2017 | $352,000 | +274.5% | 20,970 | +395.6% | 0.00% | – |
Q1 2017 | $94,000 | +46.9% | 4,231 | +7.1% | 0.00% | – |
Q4 2016 | $64,000 | -99.9% | 3,950 | -0.3% | 0.00% | – |
Q3 2016 | $53,394,000 | -44.7% | 3,961 | +0.2% | 0.00% | – |
Q2 2016 | $96,502,000 | – | 3,955 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. VI, L.L.C. | 4,656,173 | $160,824,000 | 96.46% |
Alphabet Inc. | 256,410 | $8,856,000 | 3.65% |
Casdin Capital, LLC | 85,470 | $2,952,000 | 3.39% |
Wildcat Capital Management, LLC | 247,768 | $8,558,000 | 2.98% |
Omega Fund Management, LLC | 105,007 | $3,627,000 | 2.52% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $59,043,000 | 2.51% |
EcoR1 Capital, LLC | 87,921 | $3,037,000 | 1.06% |
Foresite Capital Management III, LLC | 14,500 | $501,000 | 0.39% |
VIKING GLOBAL INVESTORS LP | 2,135,523 | $73,761,000 | 0.32% |
Schonfeld Strategic Advisors LLC | 9,726 | $336,000 | 0.14% |